日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TFE3 fusion proteins drive TFE3 rearranged renal cell carcinoma progression via PGC-1α-mediated fatty acid oxidation.

TFE3 融合蛋白通过 PGC-1α 介导的脂肪酸氧化驱动 TFE3 重排肾细胞癌的进展。

Feng Fan, Xu Yanhao, Deng Zhenggen, Dong Xiang, Chen Guijuan, Ma Wenliang, Li Dongmei, Gan Weidong

Comprehensive analysis of PANoptosis-related molecular subtypes and prognostic model development of clear cell renal cell carcinoma.

PANoptosis相关分子亚型的综合分析及透明细胞肾细胞癌预后模型的建立。

Zhou Peng, Xu Zhen, Gan Weidong, Jin Xin

Mesoscopic modeling the interaction of two attached-wall cavitation bubbles

介观尺度下两个附着壁空化气泡相互作用的建模

Gan, Weidong; Li, Shicheng; He, Xiaolong; Ma, Dianguang

TFE3 fusion proteins promoted the progression of Xp11.2 translocation renal cell carcinoma through post-translational modification of PDL1 by upregulating CCND1/Cyclin D1.

TFE3 融合蛋白通过上调 CCND1/Cyclin D1 对 PDL1 进行翻译后修饰,促进 Xp11.2 易位肾细胞癌的进展。

Lu Yanwen, Chen Yi, Pan Xinghe, Ma Wenliang, Liu Ning, Yang Lei, Dong Xiang, Guo Hongqian, Li Dongmei, Gan Weidong

The early therapeutic efficacy of robot-assisted laparoscopic radical prostatectomy with combined anterior and posterior approach: a cohort study

机器人辅助腹腔镜根治性前列腺切除术联合前后入路早期疗效:一项队列研究

Feng, Fan; Cui, Yuanshan; Pan, Xinghe; Dong, Xiang; Ma, Wenliang; Pan, Jun; Gan, Weidong; Guo, Hongqian

Transcriptionally up-regulation of CDKN1A/p21 by TFE3 fusion proteins worsened TFE3-rearranged renal cell carcinoma.

TFE3 融合蛋白对 CDKN1A/p21 的转录上调加剧了 TFE3 重排的肾细胞癌

Lu Yanwen, Ma Wenliang, Chen Yi, Dong Xiang, Pan Xinghe, Yang Lei, Zhou Shuoming, Liu Ning, Li Dongmei, Gan Weidong

Mechanistic study of TFE3 breakage in TFE3-rearranged renal cell carcinoma: the perspective of non-canonical DNA structures and their stability

TFE3重排肾细胞癌中TFE3断裂的机制研究:非经典DNA结构及其稳定性视角

Zhang, Xiaopo; Dang, Qinshuang; Pan, Xinghe; Deng, Zhenggen; Xu, Yanhao; Gan, Weidong; Guo, Hongqian

MED15-TFE3 rearranged renal cell carcinoma: a subtype of TFE3-rearranged renal cell carcinoma with unique clinicopathologic features and better prognosis.

MED15-TFE3 重排肾细胞癌:一种 TFE3 重排肾细胞癌亚型,具有独特的临床病理特征和较好的预后。

Deng Zhenggen, Xu Yanhao, Duan Enjia, Zhang Xiaopo, Dong Xiang, Guo Hongqian, Gan Weidong

Patient-derived organoids based on targeted biopsy of primary prostate cancer: development, identification, and drug screening

基于原发性前列腺癌靶向活检的患者来源类器官:构建、鉴定和药物筛选

Qian, Jiajun; Peng, Shan; Gao, Jie; Fu, Yao; Huang, Haifeng; Wu, Cheng; Gan, Weidong; Qiu, Xuefeng; Guo, Hongqian

GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A

GALNT12通过BMPR1A的O-糖基化激活BMP通路,从而抑制骨特异性前列腺癌转移。

Yang, Yang; Ding, Meng; Yin, Haoli; Chen, Wei; Shen, Hongwei; Diao, Wenli; Yang, Lin; Qin, Haixiang; Gan, Weidong; Qiu, Xuefeng; Guo, Hongqian